Beijing Chieftain Control Engineering Technology Co., Ltd. Stock

Equities

300430

CNE100001YS5

Industrial Machinery & Equipment

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
18.06 CNY +6.30% Intraday chart for Beijing Chieftain Control Engineering Technology Co., Ltd. +16.29% +26.38%

Financials

Sales 2024 * 1.39B 193M 263M Sales 2025 * 1.64B 227M 310M Capitalization 5.1B 705M 962M
Net income 2024 * 222M 30.66M 41.86M Net income 2025 * 288M 39.78M 54.3M EV / Sales 2024 * 3.66 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3.11 x
P/E ratio 2024 *
22.3 x
P/E ratio 2025 *
17.2 x
Employees 1,665
Yield 2024 *
-
Yield 2025 *
-
Free-Float 57.69%
More Fundamentals * Assessed data
Dynamic Chart
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date 12 July 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for the Year 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers. CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 July 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for 2021 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
More news
1 day+6.30%
1 week+16.29%
Current month+1.46%
1 month+13.73%
3 months+49.50%
6 months+14.09%
Current year+26.38%
More quotes
1 week
14.98
Extreme 14.98
18.16
1 month
13.61
Extreme 13.61
20.17
Current year
7.85
Extreme 7.85
20.17
1 year
7.85
Extreme 7.85
20.17
3 years
7.85
Extreme 7.85
20.17
5 years
6.70
Extreme 6.7
20.17
10 years
6.50
Extreme 6.5
48.44
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 20-06-09
Founder 55 03-07-21
Director of Finance/CFO 49 20-06-30
Members of the board TitleAgeSince
Founder 55 03-07-21
Director/Board Member 61 11-04-30
Director/Board Member 52 17-05-25
More insiders
Date Price Change Volume
24-04-29 18.72 +3.65% 16,175,820
24-04-26 18.06 +6.30% 13,431,880
24-04-25 16.99 +0.30% 10,923,460
24-04-24 16.94 +3.74% 11,125,480
24-04-23 16.33 +7.36% 11,279,560

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
Beijing Chieftain Control Engineering Technology Co., Ltd. is a China-based company primarily engaged in the provision of medical and biological industrial automation control system integrated solutions. The Company focuses on automation control applications in the production process of pharmaceutical and biotechnology products, and provides automation control system products and integrated solutions to large and medium sized pharmaceutical, biotechnology companies, based on independent research and development of core technologies and independent produced key equipment and components. Its main products include four series: Fermentation and Synthesis, Purification, Product Preparation, as well as Auxiliary Process.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
18.06
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300430 Stock